Ibrutinib: First Global Approval
Year: 2014
Type: review
Source: Drugs
Authors: Fiona Cameron, Mark Sanford
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: ibrutinib, BTK inhibitors, mantle cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, diffuse large B-cell lymphoma, multiple myeloma, follicular lymphoma, Waldenström macroglobulinemia, breakthrough therapy designation, regulatory approval, drug development milestones
Open Access status: closed
OpenAlex ID: W2107307057
